Inventor · disambiguated record
Edward Bowman
Also filed as: BOWMAN EDWARD · BOWMAN EDWARD P · BOWMAN EDWARD PAUL
16 granted patents·9 pending applications·178 citations·filing 2001–2025
93Inventor score
Files withMERCK SHARP & DOHME LLC7SCHERING CORP7MERCK SHARP & DOHME6BOWMAN EDWARD P3PRESTA LEONARD G2
Top patents by PatentIndex Score
25 records- 0196US10323090B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jun 18, 2019·26 cites·31 claims
- 0293US10544222B2PD1/CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jan 28, 2020·22 cites·15 claims
- 0393US7846443B2Antibodies to IL-17ASCHERING CORP·Filed 2007·Granted Dec 7, 2010·22 cites·19 claims
- 0493US7575741B2Methods of treating cutaneous ulcers and grafts using IL-23SCHERING CORP·Filed 2008·Granted Aug 18, 2009·27 cites·15 claims
- 0592US7332156B2Methods of treating wounds using IL-23SCHERING CORP·Filed 2003·Granted Feb 19, 2008·46 cites·15 claims
- 0691US11155619B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Oct 26, 2021·4 cites·8 claims
- 0791US7893215B2Agonist antibodies to IL-23 receptorSCHERING CORP·Filed 2009·Granted Feb 22, 2011·17 cites·8 claims
- 0887US11168136B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Nov 9, 2021·2 cites·18 claims
- 0987US11168135B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Nov 9, 2021·2 cites·16 claims
- 1083US8753843B2Antibodies to IL-17APRESTA LEONARD G·Filed 2010·Granted Jun 17, 2014·5 cites·8 claims
- 1179US12351630B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 8, 2025·0 cites·7 claims
- 1271US8193319B2Antibodies to IL-17APRESTA LEONARD G·Filed 2010·Granted Jun 5, 2012·1 cites·4 claims
- 1371US2024101631A1Human interleukin-2 conjugates biased for the interleukin-2 receptor beta-gammac dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1470US8062634B2Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptorBOWMAN EDWARD P·Filed 2011·Granted Nov 22, 2011·2 cites·9 claims
- 1568US6824781B2Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonistSCHERING CORP·Filed 2001·Granted Nov 30, 2004·2 cites·13 claims
- 1665US11827684B2Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 28, 2023·0 cites·54 claims
- 1760US2025289890A1Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agentsMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1860US2025034258A1Blocking and non-blocking single domain antibodies and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1959US2010135998A1Combination therapy for treatment of immune disordersSCHERING CORP·Filed 2008·Application pending·0 cites
- 2057US2024358847A1Trop2 binders and conjugates thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2154US2013287775A1Combination therapy for treatment of immune disordersMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2252US12358986B2Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocking agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 15, 2025·0 cites·5 claims
- 2349US2012052044A1Uses of mammalian cytokine; related reagentsBOWMAN EDWARD P·Filed 2011·Application pending·0 cites
- 2447US2010239590A1Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint diseaseSCHERING CORP·Filed 2008·Application pending·0 cites
- 2545US2012156699A1Pathogenic TH17 Cells; related reagents and methodsBOWMAN EDWARD P·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edward Bowman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →